Insys Therapeutics, Inc. IPO Research Information

Insys Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Insys Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Insys Therapeutics, Inc.	INSY - NASDAQ	$16.00-$18.00	$8.00	$8.50	4 million	5/2/2013
Underwriter(s): Wells Fargo Securities, JMP Securities
Co-Manager(s): Oppenheimer & Co.
Industry: Health Care
Filing(s):

Insys Therapeutics, Inc. Quote & Chart - Click for current quote - INSY

About Insys Therapeutics, Inc. (adapted from Insys Therapeutics, Inc. prospectus):
They are a specialty pharma preparing to commercialize a fentanyl spray to treat breakthrough cancer pain.

This description is adapted from Insys prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Insys "INSY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.